ホーム › 肺がん › モンタナ州 › Billings

Billings、MTにおける肺がんの臨床試験

Billingsとその周辺地域（約30マイル以内）の拠点で、肺がんに関する13件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。

公式研究テキスト（英語）

ここで研究参加者を募集していますか？このページの上部に表示できます — 30日間 $99 →

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

被験者募集中第3相

Billings Clinic Cancer Center, Billings

18歳以上 · 全性別 · 2026/10/02更新 · NCT04267848

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

被験者募集中観察研究健康なボランティア歓迎

Billings Clinic Cancer Center, Billings

40歳〜75歳 · 全性別 · 2026/10/02更新 · NCT05334069

Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial

被験者募集中第3相

Billings Clinic Cancer Center, Billings

70歳以上 · 全性別 · 2026/10/01更新 · NCT06096844

Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer

被験者募集中第3相

Billings Clinic Cancer Center, Billings

18歳以上 · 全性別 · 2026/10/01更新 · NCT04181060

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

被験者募集中第3相

Billings Clinic Cancer Center, Billings
Saint Vincent Frontier Cancer Center, Billings

18歳以上 · 全性別 · 2026/10/01更新 · NCT06498635

Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)

被験者募集中第3相

St. Vincent Frontier Cancer Center, Billings

18歳以上 · 全性別 · 2026/09/29更新 · NCT06881784

This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.

被験者募集中第3相

SCL Health - Montana, Billings
SCL Health - Montana, Billings

18歳以上 · 全性別 · 2026/09/25更新 · NCT06758401

Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer

被験者募集中第3相

Billings Clinic Cancer Center, Billings

18歳以上 · 全性別 · 2026/08/17更新 · NCT05624996

Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC

被験者募集中第1/2相

Intermountain Health - St. Vincent Frontier Cancer Center, Billings

18歳以上 · 全性別 · 2026/06/30更新 · NCT06162221

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

被験者募集中第2相

Billings Clinic Cancer Center, Billings

18歳以上 · 全性別 · 2026/06/03更新 · NCT05642572

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

被験者募集中第2相

Billings Clinic Cancer Center, Billings

18 Minutes · 全性別 · 2026/05/05更新 · NCT06031688

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

被験者募集中第2/3相

Billings Clinic Cancer Center, Billings

18歳以上 · 全性別 · 2026/05/05更新 · NCT06616584

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

被験者募集中観察研究

Massive Bio SYNERGY-AI site, Billings

全年齢 · 全性別 · 2025/10/28更新 · NCT03452774

他の都市における肺がんの試験

Billingsにおける他の研究

ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。